Rapid Micro Biosystems (RPID) Capital Expenditures Growth (1y) (2021 - 2026)
Rapid Micro Biosystems (RPID) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | -47.73% |
| 10 | Rapid Micro Biosystems | 89.73 Mn | 80.30 Mn | 371,000.00 | -95.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.92% |
| Dec 31, 2025 | -155.80% |
| Sep 30, 2025 | 2,255.17% |
| Jun 30, 2025 | 58.36% |
| Mar 31, 2025 | -45.47% |
| Dec 31, 2024 | 739.71% |
| Sep 30, 2024 | 211.54% |
| Jun 30, 2024 | -10.78% |
| Mar 31, 2024 | -22.92% |
| Dec 31, 2023 | 96.58% |
| Sep 30, 2023 | -100.47% |
| Jun 30, 2023 | 73.19% |
| Mar 31, 2023 | -67.74% |
| Dec 31, 2022 | -655.27% |
| Sep 30, 2022 | 642.84% |
| Jun 30, 2022 | -1,299.29% |
| Mar 31, 2022 | 837.45% |
| Dec 31, 2021 | 215.19% |
| Sep 30, 2021 | 297.62% |